Compare ALXO & TOUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALXO | TOUR |
|---|---|---|
| Founded | 2015 | 2006 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Transportation Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 79.7M | 87.0M |
| IPO Year | 2020 | 2014 |
| Metric | ALXO | TOUR |
|---|---|---|
| Price | $1.41 | $0.76 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $3.30 | N/A |
| AVG Volume (30 Days) | ★ 350.9K | 107.9K |
| Earning Date | 11-07-2025 | 12-05-2025 |
| Dividend Yield | N/A | ★ 4.79% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.03 |
| Revenue | N/A | ★ $75,532,120.00 |
| Revenue This Year | N/A | $12.27 |
| Revenue Next Year | N/A | $10.18 |
| P/E Ratio | ★ N/A | $22.37 |
| Revenue Growth | N/A | ★ 7.57 |
| 52 Week Low | $0.40 | $0.70 |
| 52 Week High | $2.27 | $1.17 |
| Indicator | ALXO | TOUR |
|---|---|---|
| Relative Strength Index (RSI) | 50.42 | 41.41 |
| Support Level | $1.29 | $0.71 |
| Resistance Level | $1.56 | $0.77 |
| Average True Range (ATR) | 0.14 | 0.04 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 48.91 | 29.69 |
ALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing a pipeline of product candidates based on expertise in protein engineering and oncology led by the CD47 blocker, evorpacept, currently in phase 1 and 2 clinical trials. Cancer cells leverage CD47, a cell surface protein, as a don't eat me signal to evade detection by the immune system. The company is developing a next-generation checkpoint inhibitor designed to have a high affinity for CD47 and to avoid the limitations caused by hematologic toxicities inherent in other CD47 blocking approaches.
Tuniu Corp is an online leisure travel company. The company is engaged in the provision of travel-related services in the People's Republic of China. It offers a large selection of packaged tours, including organized tours and self-guided tours, as well as travel-related services for leisure travelers. The company's organized tours provide pre-arranged itineraries, transportation, accommodations, entertainment, meals, and tour guide services. Its self-guided tours consist of combinations of flights and hotel bookings and other optional add-ons. The company derives almost all of its revenue from PRC.